The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase 2 study of pomalidomide/dexamethasone with or without elotuzumab in patients with relapsed/refractory multiple myeloma.
 
Jesus San Miguel
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium; MSD; Novartis; Onyx
 
Marc S. Raab
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Novartis
Research Funding - Amgen; Novartis
Travel, Accommodations, Expenses - Amgen; Celgene; Novartis
 
Hartmut Goldschmidt
Honoraria - Celgene; Chugai Pharma; Janssen; Millennium; Novartis; Onyx
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Onyx (Inst); Takeda (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Chugai Pharma (Inst); Janssen (Inst); Millennium (Inst); Novartis (Inst)
 
Sagar Lonial
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Millennium; Novartis; Onyx; Sanofi
 
Paul G. Richardson
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genmab; Johnson & Johnson; Millennium; Novartis; Oncopeptides
Research Funding - Celgene; Millennium
 
Suresh Shelat
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Eric W. Bleickardt
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Antonio Palumbo
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Novartis; Onyx; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Onyx